Indiva NDVAF Stock
Indiva Price Chart
Indiva NDVAF Financial and Trading Overview
Indiva stock price | 0.02 USD |
Previous Close | 0.07 USD |
Open | 0.07 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.06 - 0.07 USD |
52 Week Range | 0.01 - 0.1 USD |
Volume | 6K USD |
Avg. Volume | 29.94K USD |
Market Cap | 11.66M USD |
Beta (5Y Monthly) | 1.362 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NDVAF Valuation Measures
Enterprise Value | 29.57M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.32371104 |
Price/Book (mrq) | 31.124998 |
Enterprise Value/Revenue | 0.821 |
Enterprise Value/EBITDA | -6.801 |
Trading Information
Indiva Stock Price History
Beta (5Y Monthly) | 1.362 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 0.1 USD |
52 Week Low | 0.01 USD |
50-Day Moving Average | 0.04 USD |
200-Day Moving Average | 0.04 USD |
NDVAF Share Statistics
Avg. Volume (3 month) | 29.94K USD |
Avg. Daily Volume (10-Days) | 41.93K USD |
Shares Outstanding | 186.24M |
Float | 112.39M |
Short Ratio | N/A |
% Held by Insiders | 38.37% |
% Held by Institutions | 0.34% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -19.27% |
Operating Margin (ttm) | 0.13% |
Gross Margin | 25.29% |
EBITDA Margin | -12.074% |
Management Effectiveness
Return on Assets (ttm) | -6.91% |
Return on Equity (ttm) | -288.64% |
Income Statement
Revenue (ttm) | 36.01M USD |
Revenue Per Share (ttm) | 0.23 USD |
Quarterly Revenue Growth (yoy) | 21.00% |
Gross Profit (ttm) | 8.15M USD |
EBITDA | -4348554 USD |
Net Income Avi to Common (ttm) | -6940105 USD |
Diluted EPS (ttm) | -0.04 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.91M USD |
Total Cash Per Share (mrq) | 0.02 USD |
Total Debt (mrq) | 21.89M USD |
Total Debt/Equity (mrq) | 5899.22 USD |
Current Ratio (mrq) | 0.854 |
Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
Operating Cash Flow (ttm) | 714.13K USD |
Levered Free Cash Flow (ttm) | -1595541 USD |
Profile of Indiva
Country | United States |
State | ON |
City | Ottawa |
Address | 333 Preston Street |
ZIP | K1S 5N4 |
Phone | 888-649-6686 |
Website | https://www.indiva.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Q&A For Indiva Stock
What is a current NDVAF stock price?
Indiva NDVAF stock price today per share is 0.02 USD.
How to purchase Indiva stock?
You can buy NDVAF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Indiva?
The stock symbol or ticker of Indiva is NDVAF.
Which industry does the Indiva company belong to?
The Indiva industry is Drug Manufacturers-Specialty & Generic.
How many shares does Indiva have in circulation?
The max supply of Indiva shares is 206.34M.
What is Indiva Price to Earnings Ratio (PE Ratio)?
Indiva PE Ratio is now.
What was Indiva earnings per share over the trailing 12 months (TTM)?
Indiva EPS is -0.01 USD over the trailing 12 months.
Which sector does the Indiva company belong to?
The Indiva sector is Healthcare.